Coloplast B.V. - Announcement no. 03/2023 - Interim Financial Report H1 2022/23

11.05.2023 - H1 2022/23 Interim financial results, H1 2022/23 1 October 2022 - 31 March 2023 Coloplast delivered Q2 organic growth of 8% and 28% EBIT margin1). Reported revenue in DKK was up by 10%. Organic growth rates by business area: Ostomy Care 6%, ... Seite 1

Related Keywords

China , ,Us Men Health ,Ostomy Care ,Continence Care ,Respiratory Care ,Skin Care ,Interventional Urology ,Chronic Care ,Wound Care ,Atos Medical ,Coloplast Finance Unternehmensanleihe 0 ,00 Bis 05 22 ,Oloplast Finance Unternehmensanleihe 2 ,75 Bis 05 30 ,25 Bis 05 22 ,